Whether a $500 million damages award against Genentech stands will likely come down to whether the California Supreme Court interprets a 32-year-old contract as establishing a fiduciary relationship between the biotech giant and a research center. That issue was the focus of Tuesday's oral argument in the long-awaited case, as the court's justices attempted to nail down exactly what constitutes a fiduciary relationship in a patent contract. The seven judges failed to give any signs about who would prevail.
Calif. High Court's Leanings Hard to See in City of Hope Patent Case
February 6, 2008
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.